Identifying thresholds for symptom relief in stable angina
Official title: Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina
Run by Imperial College London · NCT05459051 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if certain blood flow measurements can help relieve chest pain in patients with stable angina who are considering a heart procedure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 58 (estimated) |
| Sponsor | Imperial College London Academic / other |
| Locations | 6 sites (Basildon and 5 other locations) |
| Trial ID | NCT05459051 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults eligible for PCI with significant single-vessel coronary stenosis and evidence of ischaemia.
✕Probably not a fit
Patients with multivessel disease, significant left main stem disease, or those who have had recent acute coronary syndrome may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to determine the invasive haemodynamic thresholds associated with symptom relief in patients with stable angina. It involves a randomized, double-blinded, placebo-controlled approach to assess the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) in 58 patients. Participants will undergo both rest and exercise physiological assessments to evaluate their angina symptoms under controlled conditions. The study focuses on patients eligible for percutaneous coronary intervention (PCI) due to significant coronary stenosis.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients suffering from stable angina by identifying specific thresholds for symptom relief.
How similar studies have gone: Previous studies have explored similar physiological assessments in angina, but this specific approach to identifying invasive thresholds is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligibility for percutaneous coronary intervention (PCI) due to angina or angina-equivalent symptoms on exertion * Anatomical evidence of significant single-vessel coronary stenosis defined by either: * ≥70% stenosis on invasive coronary angiography (ICA) * Severe stenosis on CT coronary angiography (CTCA) * Physiological evidence of ischaemia with a positive test on at least one of the following: * Stress echocardiography * Cardiac magnetic resonance perfusion * Myocardial perfusion scintigraphy * Invasive metrics of coronary physiology Exclusion Criteria: * Age \<18 years * Recent acute coronary syndrome * Previous coronary artery by-pass graft * Significant left main stem disease * Multivessel disease (defined as \>50% angiographic stenosis in other vessels) * Chronic total occlusion in the target artery * Moderate to severe valvular disease * Moderate to severe left ventricular impairment * Chronotropic incompetence with a pacemaker * Contraindication to PCI or a drug-eluting stents * Contraindication to antiplatelet therapy * Contraindication to adenosine * Moderate to severe respiratory disease * Physical inability to exercise * Pregnant * Inability to consent
Where it's running
-
Mid and South Essex NHS Foundation Trust
Basildon, United Kingdom Recruiting -
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Bournemouth, United Kingdom Recruiting -
Imperial College NHS Trust
London, United Kingdom Recruiting -
Royal Free Hospital NHS Foundation Trust
London, United Kingdom Recruiting -
St George's University Hospitals NHS Foundation Trust
London, United Kingdom Recruiting -
Portsmouth Hospitals NHS Trust
Portsmouth, United Kingdom Recruiting
Study contacts
- Principal investigator: Rasha Al-Lamee, PhD MRCP — Imperial College London
- Study coordinator: Fiyyaz Ahmed-Jushuf, MBBS MRCP
- Email: fiyyaz.ahmed-jushuf09@imperial.ac.uk
- Phone: 020 7594 5735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
OCT-guided stent optimization to shorten dual antiplatelet therapy for stable angina
It will test whether using OCT to optimize stent placement lets people with stable angina who get PCI safely use a shorter course of dual antiplatelet therapy.
-
Registry for coronary intervention using drug-eluting balloons for left main disease
This study is testing a new balloon technique for treating patients with left main coronary artery disease to see if it is safe and effective.
-
Investigating the effects of balloon occlusion on angina in patients with multi-vessel coronary artery disease
This study is testing how different blockages in the heart's arteries affect chest pain in people with multiple artery problems.
-
Using telemedicine for home-based cardiac rehabilitation
This study is testing whether a home-based heart rehab program using telemedicine can help people improve their health and quality of life after heart issues.
-
Assessing treatment strategies for chronic coronary syndrome
This study is testing whether getting heart surgery sooner or sticking with medication helps people with chronic coronary syndrome feel better after three months.
-
Registry of patients undergoing heart revascularization procedures
This study collects information on patients with coronary artery disease who have heart procedures to see how well they do and what factors affect their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.